TRDA vs W · P/E 12, rev $210.8M vs rev $11.85B
Entrada Therapeutics Inc (TRDA) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. W currently screens at market cap $10.77B.
Not investment advice. Open the TRDA and W stock pages for the full models.
Not investment advice.